Filed: 8/14/2023ACC: 0001420506-23-001582
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 82 equity positions with a total reported market value of $323.28M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
82
Positions
$323.28M
Total AUM (reported)
30.30M
Total Shares
Allocation by class
EQUITIES$296.15M91.6%
LONG OPTION CALLS$27.10M8.4%
WARRANTS$19.9K0.0%
Portfolio Concentration
Top 3$56.78M17.6%
4–10$84.60M26.2%
11–25$90.08M27.9%
Rest$91.83M28.4%
Top 3 weight
17.6%
Top 10 weight
43.7%
Voting Authority Distribution
Total shares with voting rights: 30.30M
Sole
Full voting authority
30.30M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole82
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings82
Rows:
ImmunoGen Inc
SOLEShares1.42M
TypeSH
Market value$26.80M
8.29%
Sole
1.42M
Shared
0.00
None
0.00
Merus NV
SOLEShares589.25K
TypeSH
Market value$15.52M
4.80%
Sole
589.25K
Shared
0.00
None
0.00
Morphic Holding Inc
SOLEShares252.31K
TypeSH
Market value$14.46M
4.47%
Sole
252.31K
Shared
0.00
None
0.00
Schrodinger Inc
SOLEShares286.17K
TypeSH
Market value$14.29M
4.42%
Sole
286.17K
Shared
0.00
None
0.00
Krystal Biotech Inc
SOLEShares118.94K
TypeSH
Market value$13.96M
4.32%
Sole
118.94K
Shared
0.00
None
0.00
Intra-Cellular Therapies Inc
SOLEShares198.72K
TypeSH
Market value$12.58M
3.89%
Sole
198.72K
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares241.36K
TypeSH
Market value$11.27M
3.49%
Sole
241.36K
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares1.45M
TypeSH
Market value$11.26M
3.48%
Sole
1.45M
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares236.50K
TypeSH
Market value$11.04M
3.41%
Sole
236.50K
Shared
0.00
None
0.00
MoonLake Immunotherapeutics
SOLEShares200K
TypeSH
Market value$10.20M
3.16%
Sole
200K
Shared
0.00
None
0.00
Biogen Idec Inc
SOLEShares26.85K
TypeSH
Market value$7.65M
2.37%
Sole
26.85K
Shared
0.00
None
0.00
89bio Inc
SOLEShares396.50K
TypeSH
Market value$7.51M
2.32%
Sole
396.50K
Shared
0.00
None
0.00
Cogent Biosciences Inc
SOLEShares620K
TypeSH
Market value$7.34M
2.27%
Sole
620K
Shared
0.00
None
0.00
Aclaris Therapeutics Inc
SOLEShares651.40K
TypeSH
Market value$6.76M
2.09%
Sole
651.40K
Shared
0.00
None
0.00
United Therapeutics Corp
SOLEShares30.03K
TypeSH
Market value$6.63M
2.05%
Sole
30.03K
Shared
0.00
None
0.00
MacroGenics Inc
SOLEShares1.22M
TypeSH
Market value$6.50M
2.01%
Sole
1.22M
Shared
0.00
None
0.00
KalVista Pharmaceuticals Inc
SOLEShares720.51K
TypeSH
Market value$6.48M
2.01%
Sole
720.51K
Shared
0.00
None
0.00
Veracyte Inc
SOLEShares229.45K
TypeSH
Market value$5.84M
1.81%
Sole
229.45K
Shared
0.00
None
0.00
Mirati Therapeutics Inc
SOLEShares150K
TypeSH
Market value$5.42M
1.68%
Sole
150K
Shared
0.00
None
0.00
BioCryst Pharmaceuticals Inc
SOLEShares760.90K
TypeSH
Market value$5.36M
1.66%
Sole
760.90K
Shared
0.00
None
0.00
Terns Pharmaceuticals Inc
SOLEShares599.67K
TypeSH
Market value$5.25M
1.62%
Sole
599.67K
Shared
0.00
None
0.00
Poseida Therapeutics Inc
SOLEShares2.95M
TypeSH
Market value$5.18M
1.60%
Sole
2.95M
Shared
0.00
None
0.00
Nuvalent Inc
SOLEShares115.07K
TypeSH
Market value$4.85M
1.50%
Sole
115.07K
Shared
0.00
None
0.00
Gilead Sciences Inc
SOLEShares60.45K
TypeSH
Market value$4.66M
1.44%
Sole
60.45K
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc
SOLEShares13.18K
TypeSH
Market value$4.64M
1.43%
Sole
13.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ImmunoGen IncSOLE | EQUITIES | 1.42M | SH | $26.80M 8.29% | 1.42M | 0.00 | 0.00 |
Merus NVSOLE | EQUITIES | 589.25K | SH | $15.52M 4.80% | 589.25K | 0.00 | 0.00 |
Morphic Holding IncSOLE | EQUITIES | 252.31K | SH | $14.46M 4.47% | 252.31K | 0.00 | 0.00 |
Schrodinger IncSOLE | EQUITIES | 286.17K | SH | $14.29M 4.42% | 286.17K | 0.00 | 0.00 |
Krystal Biotech IncSOLE | EQUITIES | 118.94K | SH | $13.96M 4.32% | 118.94K | 0.00 | 0.00 |
Intra-Cellular Therapies IncSOLE | EQUITIES | 198.72K | SH | $12.58M 3.89% | 198.72K | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | EQUITIES | 241.36K | SH | $11.27M 3.49% | 241.36K | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | EQUITIES | 1.45M | SH | $11.26M 3.48% | 1.45M | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | LONG OPTION CALLS | 236.50K | SH | $11.04M 3.41% | 236.50K | 0.00 | 0.00 |
MoonLake ImmunotherapeuticsSOLE | EQUITIES | 200K | SH | $10.20M 3.16% | 200K | 0.00 | 0.00 |
Biogen Idec IncSOLE | EQUITIES | 26.85K | SH | $7.65M 2.37% | 26.85K | 0.00 | 0.00 |
89bio IncSOLE | EQUITIES | 396.50K | SH | $7.51M 2.32% | 396.50K | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | EQUITIES | 620K | SH | $7.34M 2.27% | 620K | 0.00 | 0.00 |
Aclaris Therapeutics IncSOLE | LONG OPTION CALLS | 651.40K | SH | $6.76M 2.09% | 651.40K | 0.00 | 0.00 |
United Therapeutics CorpSOLE | EQUITIES | 30.03K | SH | $6.63M 2.05% | 30.03K | 0.00 | 0.00 |
MacroGenics IncSOLE | EQUITIES | 1.22M | SH | $6.50M 2.01% | 1.22M | 0.00 | 0.00 |
KalVista Pharmaceuticals IncSOLE | EQUITIES | 720.51K | SH | $6.48M 2.01% | 720.51K | 0.00 | 0.00 |
Veracyte IncSOLE | EQUITIES | 229.45K | SH | $5.84M 1.81% | 229.45K | 0.00 | 0.00 |
Mirati Therapeutics IncSOLE | LONG OPTION CALLS | 150K | SH | $5.42M 1.68% | 150K | 0.00 | 0.00 |
BioCryst Pharmaceuticals IncSOLE | EQUITIES | 760.90K | SH | $5.36M 1.66% | 760.90K | 0.00 | 0.00 |
Terns Pharmaceuticals IncSOLE | EQUITIES | 599.67K | SH | $5.25M 1.62% | 599.67K | 0.00 | 0.00 |
Poseida Therapeutics IncSOLE | EQUITIES | 2.95M | SH | $5.18M 1.60% | 2.95M | 0.00 | 0.00 |
Nuvalent IncSOLE | EQUITIES | 115.07K | SH | $4.85M 1.50% | 115.07K | 0.00 | 0.00 |
Gilead Sciences IncSOLE | EQUITIES | 60.45K | SH | $4.66M 1.44% | 60.45K | 0.00 | 0.00 |
Vertex Pharmaceuticals IncSOLE | EQUITIES | 13.18K | SH | $4.64M 1.43% | 13.18K | 0.00 | 0.00 |
Page 1 of 4